Literature DB >> 22165864

2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report.

Alvin C Bronstein1, Daniel A Spyker, Louis R Cantilena, Jody L Green, Barry H Rumack, Richard C Dart.   

Abstract

BACKGROUND: This is the 28th Annual Report of the American Association of Poison Control Centers' (AAPCC) National Poison Data System (NPDS). All US poison centers upload case data automatically with a median time interval of 19.0 [11.9, 40.6] (median [25%, 75%]) minutes, creating a near real-time national exposure and information database and surveillance system.
METHODOLOGY: We analyzed the case data tabulating specific indices from NPDS. The methodology was similar to that of previous years. Where changes were introduced, the differences are identified. Poison center cases with medical outcomes of death were evaluated by a team of 33 medical and clinical toxicologist reviewers using an ordinal scale of 1 (Undoubtedly responsible) - 6 (Unknown) to determine Relative Contribution to Fatality (RCF) of the exposure to the death.
RESULTS: In 2010, 3,952,772 closed encounters were logged by NPDS: 2,384,825, human exposures, 94,823 animal exposures, 1,466,253 information calls, 6537 human confirmed nonexposures, and 334 animal confirmed nonexposures. Total encounters showed a 7.7% decline from 2009 while health care facility calls increased by 2.7%. Human exposures with more serious outcomes (minor, moderate, major or death) increased 4.5% while those with less serious outcomes (all other medical outcome categories) decreased 5.9%. All information calls decreased 12.6% and health care facility (HCF) information calls decreased 13.6%, Drug ID calls decreased 10.9%, and human exposures decreased 3.8%. The top 5 substance classes most frequently involved in all human exposures were analgesics (11.5%), cosmetics/personal care products (7.7%), household cleaning substances (7.3%), sedatives/hypnotics/ antipsychotics (6.0%), and foreign bodies/toys/miscellaneous (4.2%). Analgesic exposures as a class increased the most rapidly by 32.8% over the last decade. The top f ve most common exposures in children age 5 years or less were cosmetics/personal care products (13.2%), analgesics (9.4%), household cleaning substances (9.2%), foreign bodies/toys/miscellaneous (7.2%), and topical preparations (6.8%). THC homolog and designer amphetamine ("Bath Salts") exposures were identified as emerging public health threats. Drug identification requests comprised 64.3% of all information calls. NPDS documented 1730 human exposures resulting in death with 1146 human fatalities judged related with an RCF of 1-Undoubtedly responsible, 2-Probably responsible, or 3-Contributory.
CONCLUSIONS: These data support the continued value of poison center expertise and need for specialized medical toxicology information to manage the more severe exposures, despite a decrease in calls involving less severe exposures. Unintentional and intentional exposures continue to be a significant cause of morbidity and mortality in the US. The near real-time, always current status of NPDS represents a national public health resource to collect and monitor US exposure cases and information calls. The continuing mission of NPDS is to provide a nationwide infrastructure for public health surveillance for all types of exposures, public health event identification, resilience response and situational awareness tracking. NPDS is a model system for the nation and global public health.

Entities:  

Mesh:

Year:  2011        PMID: 22165864     DOI: 10.3109/15563650.2011.635149

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  86 in total

Review 1.  Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management.

Authors:  Michael Levine; Anne-Michelle Ruha
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  Laundry detergent capsules and pediatric poisoning.

Authors:  Asha G Bonney; Suzan Mazor; Ran D Goldman
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

3.  Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products.

Authors:  David Goldberger; David Vearrier
Journal:  J Med Toxicol       Date:  2017-07-14

Review 4.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

5.  Fatal metformin overdose: case report and postmortem biochemistry contribution.

Authors:  Alessandro Bonsignore; Fulvia Pozzi; Giulio Fraternali Orcioni; Francesco Ventura; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2013-11-08       Impact factor: 2.686

6.  The potential detrimental effects of calcium channel blockers' overdose and current available management.

Authors:  Manyoo A Agarwal; David Flatt; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

7.  Nutmeg poisonings: a retrospective review of 10 years experience from the Illinois Poison Center, 2001-2011.

Authors:  Jamie E Ehrenpreis; Carol DesLauriers; Patrick Lank; P Keelan Armstrong; Jerrold B Leikin
Journal:  J Med Toxicol       Date:  2014-06

8.  Age-dependent MDPV-induced taste aversions and thermoregulation in adolescent and adult rats.

Authors:  Andrew P Merluzzi; Zachary E Hurwitz; Maria A Briscione; Jennifer L Cobuzzi; Bradley Wetzell; Kenner C Rice; Anthony L Riley
Journal:  Dev Psychobiol       Date:  2013-10-04       Impact factor: 3.038

Review 9.  Pediatric renal replacement therapy in the intensive care unit.

Authors:  Brian C Bridges; David J Askenazi; Jessimene Smith; Stuart L Goldstein
Journal:  Blood Purif       Date:  2012-10-24       Impact factor: 2.614

10.  Detection of α-, β-, and γ-amanitin in urine by LC-MS/MS using 15N10-α-amanitin as the internal standard.

Authors:  Nicole L Abbott; Kasey L Hill; Alaine Garrett; Melissa D Carter; Elizabeth I Hamelin; Rudolph C Johnson
Journal:  Toxicon       Date:  2018-07-30       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.